News
R&D project spotlight: Enhancing DNA impurity detection in AAV through automation of the PicoGreen assay
Cell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024Regulatory Round-up - August 2024Regulatory Round-up - July 2024Challenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsPatient first: Highlights from the RSM’s “Unveiling Gene Therapy: Transforming medical practice through ATMPs” eventCGT Catapult establishes consortium to improve AAV formulationRegulatory Round-up - June 2024Plurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesRegulatory Round-up - May 2024CATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturingCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platform